Identification of Chlorophyll A-b Binding Protein AB96 As a Novel TGFβ1 Neutralizing Agent

Overview

Journal Sci Rep

Specialty Science

Date 2021 Apr 9

PMID 33833368

Citations 1

Authors

Steven Lynham

Fabio Grundland Freile

Natasha M Puri

Nicola OReilly

Graham H Mitchell

Timothy N C Wells

Merlin Willcox

Richard Beatson

Affiliations

Soon will be listed here.

Abstract

The discovery of compounds and proteins from plants has greatly contributed to modern medicine. Vernonia amygdalina Del. (Compositae) is used by humans and primates for a variety of conditions including parasitic infection. This paper describes the serendipitous discovery that V. amygdalina extract was able to bind to, and functionally inhibit, active TGFβ1. The binding agent was isolated and identified as chlorophyll a-b binding protein AB96. Given that active TGFβ1 contributes to the pathology of many infectious diseases, inhibiting these processes may explain some of the benefits associated with the ingestion of this species. This is the first plant-derived cytokine-neutralizing protein to be described and paves the way for further such discoveries.

Citing Articles

Nanopore-Based Comparative Transcriptome Analysis Reveals the Potential Mechanism of High-Temperature Tolerance in Cotton ( L.).

Liang Y, Gong Z, Wang J, Zheng J, Ma Y, Min L Plants (Basel). 2021; 10(11).

PMID: 34834881 PMC: 8618236. DOI: 10.3390/plants10112517.

References

Marshall J, Jankowski A, Furesz S, Kireeva I, Barker L, Dombrovsky M . Human serum proteins preseparated by electrophoresis or chromatography followed by tandem mass spectrometry. J Proteome Res. 2004; 3(3):364-82. DOI: 10.1021/pr034039p. View

Grainger J, Smith K, Hewitson J, McSorley H, Harcus Y, Filbey K . Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J Exp Med. 2010; 207(11):2331-41. PMC: 2964568. DOI: 10.1084/jem.20101074. View

Wahl S, Wen J, Moutsopoulos N . TGF-beta: a mobile purveyor of immune privilege. Immunol Rev. 2006; 213:213-27. DOI: 10.1111/j.1600-065X.2006.00437.x. View

Challand S, Willcox M . A clinical trial of the traditional medicine Vernonia amygdalina in the treatment of uncomplicated malaria. J Altern Complement Med. 2009; 15(11):1231-7. DOI: 10.1089/acm.2009.0098. View

Omer F, de Souza J, Corran P, Sultan A, Riley E . Activation of transforming growth factor beta by malaria parasite-derived metalloproteinases and a thrombospondin-like molecule. J Exp Med. 2003; 198(12):1817-27. PMC: 2194152. DOI: 10.1084/jem.20030713. View

Beatson R, Maurstad G, Picco G, Arulappu A, Coleman J, Wandell H . The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL. PLoS One. 2015; 10(5):e0125994. PMC: 4423978. DOI: 10.1371/journal.pone.0125994. View

Iwalokun B . Enhanced antimalarial effects of chloroquine by aqueous Vernonia amygdalina leaf extract in mice infected with chloroquine resistant and sensitive Plasmodium berghei strains. Afr Health Sci. 2009; 8(1):25-35. PMC: 2408548. View

Johnston C, Smyth D, Kodali R, White M, Harcus Y, Filbey K . A structurally distinct TGF-β mimic from an intestinal helminth parasite potently induces regulatory T cells. Nat Commun. 2017; 8(1):1741. PMC: 5701006. DOI: 10.1038/s41467-017-01886-6. View

Toyang N, Verpoorte R . A review of the medicinal potentials of plants of the genus Vernonia (Asteraceae). J Ethnopharmacol. 2013; 146(3):681-723. DOI: 10.1016/j.jep.2013.01.040. View

10.

Torcia M, Santarlasci V, Cosmi L, Clemente A, Maggi L, Mangano V . Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria. Proc Natl Acad Sci U S A. 2008; 105(2):646-51. PMC: 2206590. DOI: 10.1073/pnas.0709969105. View

11.

Abosi A, Raseroka B . In vivo antimalarial activity of Vernonia amygdalina. Br J Biomed Sci. 2003; 60(2):89-91. DOI: 10.1080/09674845.2003.11783680. View

12.

Annes J, Munger J, Rifkin D . Making sense of latent TGFbeta activation. J Cell Sci. 2002; 116(Pt 2):217-24. DOI: 10.1242/jcs.00229. View

13.

Njan A, Adzu B, Agaba A, Byarugaba D, Diaz-Llera S, Bangsberg D . The analgesic and antiplasmodial activities and toxicology of Vernonia amygdalina. J Med Food. 2008; 11(3):574-81. DOI: 10.1089/jmf.2007.0511. View

14.

Wells T . Natural products as starting points for future anti-malarial therapies: going back to our roots?. Malar J. 2011; 10 Suppl 1:S3. PMC: 3059461. DOI: 10.1186/1475-2875-10-S1-S3. View

15.

Salek-Ardakani S, Stuart A, Arrand J, Lyons S, Arrand J, Mackett M . High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin 10: efficient removal of endotoxin. Cytokine. 2002; 17(1):1-13. DOI: 10.1006/cyto.2001.0990. View

16.

Scholzen A, Mittag D, Rogerson S, Cooke B, Plebanski M . Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta. PLoS Pathog. 2009; 5(8):e1000543. PMC: 2718810. DOI: 10.1371/journal.ppat.1000543. View

17.

Beatson R, Tajadura-Ortega V, Achkova D, Picco G, Tsourouktsoglou T, Klausing S . The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016; 17(11):1273-1281. PMC: 5257269. DOI: 10.1038/ni.3552. View

18.

Ohigashi H, Huffman M, Izutsu D, Koshimizu K, Kawanaka M, Sugiyama H . Toward the chemical ecology of medicinal plant use in chimpanzees: The case ofVernonia amygdalina, a plant used by wild chimpanzees possibly for parasite-related diseases. J Chem Ecol. 2013; 20(3):541-53. DOI: 10.1007/BF02059596. View

19.

Duru V, Witkowski B, Menard D . Plasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia. Am J Trop Med Hyg. 2016; 95(6):1228-1238. PMC: 5154433. DOI: 10.4269/ajtmh.16-0234. View

20.

LoVerde P, Osman A, Hinck A . Schistosoma mansoni: TGF-beta signaling pathways. Exp Parasitol. 2007; 117(3):304-17. PMC: 2149906. DOI: 10.1016/j.exppara.2007.06.002. View